Results of your search
-
Anna-Lena Engwall - Global Vice President and Franchise Head, Cardiovascular & Acute Care - has a Bachelor of Science in Nursing from Karolinska Institute.AstraZeneca - Pharmaceuticals - United Kingdom (UK)
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Ardelyx - Biotechnology - United States (USA)
-
Carl Kilander - Director - has a Doctor of Medicine from Karolinska Institute and PhD from Karolinska Institute.Adcendo - Biotechnology - Denmark
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Arrakis Therapeutics - Biotechnology - United States (USA)
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.A2 Biotherapeutics - Biotechnology - United States (USA)
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Alligator Bioscience - Biotechnology - Sweden
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Anocca - Biotechnology - Sweden
-
Jan Lundberg - Director - has a PhD from Karolinska Institute and Medical Degree from University of Gothenburg.Ferring Pharmaceuticals - Pharmaceuticals - Switzerland
-
Johan Luthman - Executive Vice President and Head of Research & Development - has a PhD, Basic Dentistry, Medicine and Neuroscience from Karolinska Institute and Doctor of Dental Surgery from Karolinska Institute.Lundbeck - Pharmaceuticals - Denmark
-
Yilmaz Mahshid - Director - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Malene Jensen - Vice President, Clinical Development - has a PhD in Clinical Neuroscience from Karolinska Institute and Master of Science in Molecular Biology from Stockholm University.Pia Baumann - Chief Medical Officer - has a PhD in Oncology from Karolinska Institute.Medivir - Biotechnology - Sweden
-
Mikael Nygard - Vice President, Business Development - has a PhD in Neuroscience from Karolinska Institute and Master of Sciences in Pharmacy from Uppsala University.Vicore Pharma - Pharmaceuticals - Sweden
-
Jakob Loven - Board Member - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.IconOVir Bio - Biotechnology - United States (USA)
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Elypta - Biotechnology - Sweden
-
Jakob Loven - Director - has a PhD in Medical Sciences from Karolinska Institute and Bachelor of Arts in Natural Sciences from University of Cambridge.Flare Therapeutics - Biotechnology - United States (USA)
-
Yilmaz Mahshid - Chief Financial Officer - has a PhD in Medical Biochemistry and Biophysics from Karolinska Institute and Master in Toxicology from Karolinska Institute.Desiree Luthman - Vice President, Global Regulatory Affairs - has a Doctor of Dental Surgery from Karolinska Institute.Egetis Therapeutics - Biotechnology - Sweden
-
Anders Ekblom - Non-Executive Director - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Mereo BioPharma - Pharmaceuticals - United Kingdom (UK)
-
Roger Tell - Director - has a Phd, Experimental Oncology from Karolinska Institute and Medical Doctorate from Karolinska Institute.Vivesto - Healthcare - Sweden
-
Hans Basun - Senior Director Clinical Development - has a Medical Doctorate from Karolinska Institute.Anna-Lena Engwall - Director (starts on May 22 2024) - has a Bachelor of Science in Nursing from Karolinska Institute.BioArctic - Biotechnology - Sweden
-
Kjell Stenberg - Chief Executive Officer - has a Doctor of Medical Science in Cellular Toxicity from Karolinska Institute and Master of Science in Biochemical Separation Technologies from Umeå University.Cyxone - Pharmaceuticals - Sweden
-
Jarl Jungnelius - Board Member - has a Doctor of Medicine from Karolinska Institute.Oncopeptides - Biotechnology - Sweden
-
Anna-Karin Maltais - Chief Scientific Officer - has a PhD in Immunobiology and Tumor Immunology, Immunotherapy, Vaccines from Karolinska Institute and Master of Science in Biology, Mathematical and Science Program from Uppsala University.XNK Therapeutics - Biotechnology - Sweden
-
Anders Ekblom - Chairman of the Board - has a Doctor of Medicine from Karolinska Institute and PhD in Physiology from Karolinska institutet Degree NamePhDField Of StudyPhysiology.Xspray Pharma - Pharmaceuticals - Sweden
-
Per Grufman - Chief Executive Officer, Biocrucible - has a PhD in Immunology from Karolinska Institute and Master of Science in biology from Stockholm University.Sapphiros - Biotechnology - United States (USA)